Navigation auf uzh.ch

Suche

Epidemiology, Biostatistics and Prevention Institute

Archive Health Research Methods

 

Project title/PI Discovery (D), Evaluation (E), Implementation (I) Link to project page

1 Minute Sit-to-Stand Test in Cystic Fibrosis

 

Susi Kriemler

D, E More…

Benefit-harm assessments to inform patient-centered care for older people with multiple chronic conditions

Milo Puhan / Hélène Aschmann

D, E More…

COGEN

Ulrike Held

D, E, I More…

Hospital and nursing home stays in Switzerland

 

Matthias Bopp

E, I More…

Immunological Correlates of COVID-19 Severity

Ulrike Held

D, E More…

Impact of the matching algorithm on the treatment effect estimate: A neutral comparison study

Ulrike Held / Priska Heinz

D, E More…

Model-Based Recursive Partitioning for Stratified Medicine

 

Torsten Hothorn

D, E, I More…

PCORI: Benefit harm assessment methods for guidelines

Milo Puhan

D, E, I More…

Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis

 

Ulrike Held

E More…

SEDA: Sensitivity diagnostics for Bayesian hierarchical models

Malgorzata Roos

D, E, I More…

Strengths and Limits of Swiss Health Statistics

 

Matthias Bopp

E More…

SURFit: Effects of a 1-year partially supervised exercise programme in childhood cancer survivors – a randomized controlled trial

 

Susi Kriemler

D, E More…

Swiss MS Registry - Registry Development

 

Viktor von Wyl

D, E, I More…

Swiss National Cohort

 

Matthias Bopp

D, E More…

The OVID trial was initiated in 2020, at the beginning of the pandemic, with the aim to demonstrate superiority of enoxaparin as compared to standard of care for primary thromboprophylaxis in ambulatory patients with coronavirus disease

 

Ulrike Held

D More…